| Dr John Anthony Savino Iii, MD | |
|
1320 Stony Brook Rd Bldg D, Stony Brook, NY 11790-2206 | |
| (212) 241-1653 | |
| (212) 289-6393 |
| Full Name | Dr John Anthony Savino Iii |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 14 Years |
| Location | 1320 Stony Brook Rd Bldg D, Stony Brook, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023332079 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 263571 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Suny/stony Brook University Hospital | Stony brook, NY | Hospital |
| John T Mather Memorial Hospital Of Port Jefferson | Port jefferson, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stony Brook Internists University Faculty Practice Corporation | 9133019821 | 362 |
News Archive
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced clinical results showing meaningful and sustained low clinical events for patients with ischemic heart failure three years following Percutaneous Ventricular Restoration (PVR) therapy with the first-of-its-kind catheter-based Parachute™ Ventricular Partitioning Device.
Frontotemporal dementia (FTD) is a progressive neurodegenerative brain disorder, which affects the frontal and temporal lobes. Unlike other types of dementia, it more commonly occurs in individuals in their 50s and 60s, and is therefore referred to as a "younger-onset dementia".
Resveratrol, a popular plant extract shown to prolong life in yeast and lower animals due to its anti-inflammatory and antioxidant properties, appears also to suppress inflammation in humans, based on results from the first prospective human trial of the extract conducted by University at Buffalo endocrinologists.
Groundbreaking studies will be presented at the ESMO 12th World Congress on Gastrointestinal Cancer next week in Barcelona, Spain, including exciting new data on treatment for neuroendocrine tumors. "The presentations this year are very significant for clinicians, and outline real progress in the development of agents that are effective in managing and treating gastrointestinal diseases," says Eric Van Cutsem, MD, PhD of the University Hospital Gasthuisberg in Leuven, Belgium and Congress co-chair.
The degeneration of a small, wishbone-shaped structure deep inside the brain may provide the earliest clues to future cognitive decline, long before healthy older people exhibit clinical symptoms of memory loss or dementia, a study by researchers with the UC Davis Alzheimer's Disease Center has found.
› Verified 9 days ago
| Entity Name | Stony Brook Internists University Faculty Practice Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295778371 PECOS PAC ID: 9133019821 Enrollment ID: O20040317000450 |
News Archive
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced clinical results showing meaningful and sustained low clinical events for patients with ischemic heart failure three years following Percutaneous Ventricular Restoration (PVR) therapy with the first-of-its-kind catheter-based Parachute™ Ventricular Partitioning Device.
Frontotemporal dementia (FTD) is a progressive neurodegenerative brain disorder, which affects the frontal and temporal lobes. Unlike other types of dementia, it more commonly occurs in individuals in their 50s and 60s, and is therefore referred to as a "younger-onset dementia".
Resveratrol, a popular plant extract shown to prolong life in yeast and lower animals due to its anti-inflammatory and antioxidant properties, appears also to suppress inflammation in humans, based on results from the first prospective human trial of the extract conducted by University at Buffalo endocrinologists.
Groundbreaking studies will be presented at the ESMO 12th World Congress on Gastrointestinal Cancer next week in Barcelona, Spain, including exciting new data on treatment for neuroendocrine tumors. "The presentations this year are very significant for clinicians, and outline real progress in the development of agents that are effective in managing and treating gastrointestinal diseases," says Eric Van Cutsem, MD, PhD of the University Hospital Gasthuisberg in Leuven, Belgium and Congress co-chair.
The degeneration of a small, wishbone-shaped structure deep inside the brain may provide the earliest clues to future cognitive decline, long before healthy older people exhibit clinical symptoms of memory loss or dementia, a study by researchers with the UC Davis Alzheimer's Disease Center has found.
› Verified 9 days ago
| Entity Name | Stony Brook Internists University Faculty Practice Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821035601 PECOS PAC ID: 9133019821 Enrollment ID: O20040416000248 |
News Archive
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced clinical results showing meaningful and sustained low clinical events for patients with ischemic heart failure three years following Percutaneous Ventricular Restoration (PVR) therapy with the first-of-its-kind catheter-based Parachute™ Ventricular Partitioning Device.
Frontotemporal dementia (FTD) is a progressive neurodegenerative brain disorder, which affects the frontal and temporal lobes. Unlike other types of dementia, it more commonly occurs in individuals in their 50s and 60s, and is therefore referred to as a "younger-onset dementia".
Resveratrol, a popular plant extract shown to prolong life in yeast and lower animals due to its anti-inflammatory and antioxidant properties, appears also to suppress inflammation in humans, based on results from the first prospective human trial of the extract conducted by University at Buffalo endocrinologists.
Groundbreaking studies will be presented at the ESMO 12th World Congress on Gastrointestinal Cancer next week in Barcelona, Spain, including exciting new data on treatment for neuroendocrine tumors. "The presentations this year are very significant for clinicians, and outline real progress in the development of agents that are effective in managing and treating gastrointestinal diseases," says Eric Van Cutsem, MD, PhD of the University Hospital Gasthuisberg in Leuven, Belgium and Congress co-chair.
The degeneration of a small, wishbone-shaped structure deep inside the brain may provide the earliest clues to future cognitive decline, long before healthy older people exhibit clinical symptoms of memory loss or dementia, a study by researchers with the UC Davis Alzheimer's Disease Center has found.
› Verified 9 days ago
| Entity Name | Cardiac Ekg Interpretation, P. C. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386665644 PECOS PAC ID: 2466345103 Enrollment ID: O20050817001042 |
News Archive
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced clinical results showing meaningful and sustained low clinical events for patients with ischemic heart failure three years following Percutaneous Ventricular Restoration (PVR) therapy with the first-of-its-kind catheter-based Parachute™ Ventricular Partitioning Device.
Frontotemporal dementia (FTD) is a progressive neurodegenerative brain disorder, which affects the frontal and temporal lobes. Unlike other types of dementia, it more commonly occurs in individuals in their 50s and 60s, and is therefore referred to as a "younger-onset dementia".
Resveratrol, a popular plant extract shown to prolong life in yeast and lower animals due to its anti-inflammatory and antioxidant properties, appears also to suppress inflammation in humans, based on results from the first prospective human trial of the extract conducted by University at Buffalo endocrinologists.
Groundbreaking studies will be presented at the ESMO 12th World Congress on Gastrointestinal Cancer next week in Barcelona, Spain, including exciting new data on treatment for neuroendocrine tumors. "The presentations this year are very significant for clinicians, and outline real progress in the development of agents that are effective in managing and treating gastrointestinal diseases," says Eric Van Cutsem, MD, PhD of the University Hospital Gasthuisberg in Leuven, Belgium and Congress co-chair.
The degeneration of a small, wishbone-shaped structure deep inside the brain may provide the earliest clues to future cognitive decline, long before healthy older people exhibit clinical symptoms of memory loss or dementia, a study by researchers with the UC Davis Alzheimer's Disease Center has found.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Anthony Savino Iii, MD 45 Research Way, Suite 105, East Setauket, NY 11733 Ph: (631) 675-2125 | Dr John Anthony Savino Iii, MD 1320 Stony Brook Rd Bldg D, Stony Brook, NY 11790-2206 Ph: (212) 241-1653 |
News Archive
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced clinical results showing meaningful and sustained low clinical events for patients with ischemic heart failure three years following Percutaneous Ventricular Restoration (PVR) therapy with the first-of-its-kind catheter-based Parachute™ Ventricular Partitioning Device.
Frontotemporal dementia (FTD) is a progressive neurodegenerative brain disorder, which affects the frontal and temporal lobes. Unlike other types of dementia, it more commonly occurs in individuals in their 50s and 60s, and is therefore referred to as a "younger-onset dementia".
Resveratrol, a popular plant extract shown to prolong life in yeast and lower animals due to its anti-inflammatory and antioxidant properties, appears also to suppress inflammation in humans, based on results from the first prospective human trial of the extract conducted by University at Buffalo endocrinologists.
Groundbreaking studies will be presented at the ESMO 12th World Congress on Gastrointestinal Cancer next week in Barcelona, Spain, including exciting new data on treatment for neuroendocrine tumors. "The presentations this year are very significant for clinicians, and outline real progress in the development of agents that are effective in managing and treating gastrointestinal diseases," says Eric Van Cutsem, MD, PhD of the University Hospital Gasthuisberg in Leuven, Belgium and Congress co-chair.
The degeneration of a small, wishbone-shaped structure deep inside the brain may provide the earliest clues to future cognitive decline, long before healthy older people exhibit clinical symptoms of memory loss or dementia, a study by researchers with the UC Davis Alzheimer's Disease Center has found.
› Verified 9 days ago
Mohamed Hassan Kamel, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: Stony Brook University Hospital 101 Nicolls Road, Stony Brook, NY 11794 Phone: 631-689-8333 | |
Narinder Singh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Nicolls Rd, Stony Brook, NY 11794 Phone: 631-444-4000 | |
Dr. Andrzej Kudelka, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Pellegrino Rd, Z8151, Stony Brook, NY 11794 Phone: 631-638-0910 Fax: 631-638-0195 | |
Saverio J Barbera, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Health Science Center Nicolls Road, T-16-080, Stony Brook, NY 11794 Phone: 631-444-3575 Fax: 631-444-1054 | |
Dr. Richard Lin, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: University Hospital, L5, Stony Brook, NY 11794 Phone: 631-444-2540 | |
Dr. Ajay Malhotra, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Hsc L4 Rm 120, Stony Brook, NY 11794 Phone: 631-444-5400 Fax: 631-444-7538 |